Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

被引:67
|
作者
Nault, Jean-Charles [1 ,4 ,5 ,6 ]
Guyot, Erwan [2 ,4 ]
Laguillier, Christelle [2 ,4 ]
Chevret, Sylvie [7 ,8 ]
Ganne-Carrie, Nathalie [1 ,4 ]
N'Kontchou, Gisele [1 ,4 ]
Beaugrand, Michel [1 ,4 ]
Seror, Olivier [3 ]
Trinchet, Jean-Claude [1 ,4 ]
Coelho, Jessica [1 ,4 ]
Lasalle, Philippe [10 ]
Charnaux, Nathalie [2 ,4 ]
Delehedde, Maryse [10 ]
Sutton, Angela [2 ,4 ]
Nahon, Pierre [1 ,9 ]
机构
[1] Hop Jean Verdier, AP HP, Serv Hepatol, Bondy, France
[2] Hop Jean Verdier, AP HP, Serv Biochim, Bondy, France
[3] Hop Jean Verdier, AP HP, Serv Radiol, Bondy, France
[4] Univ Paris 13, UFR SMBH, INSERM, U698, Bobigny, France
[5] INSERM, UMR 674, IUH, Paris, France
[6] Univ Paris 05, Fac Med, Labex Immunooncol, Sorbonne Paris Cite, Paris, France
[7] Hop St Louis, AP HP, Dept Biostat, Paris, France
[8] Univ Paris Diderot, INSERM, Unite Biostat & Epidemiol Clin, UMR S717, Paris, France
[9] Univ Paris 07, INSERM, Ctr Rech Bichat Beaujon CRB3, U773, Paris, France
[10] Inst Pasteur, Lille, France
关键词
ENDOCAN EXPRESSION; VASCULAR ENDOCAN; GROWTH-FACTOR; SYNDECAN-1; GLYPICAN-3; SURVIVAL; MARKER; MANAGEMENT; ESM-1;
D O I
10.1158/1055-9965.EPI-13-0179
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Proteoglycans are involved in neoangiogenesis and transduction of oncogenic signals, two hallmarks of carcinogenesis. Methods: This study sought to assess the prognostic value of serum levels of three proteoglycans (endocan, syndecan-1, and glypican-3) and VEGF in 295 patients with alcoholic cirrhosis: 170 without hepatocellular carcinoma, 58 with early hepatocellular carcinoma, and 67 with advanced hepatocellular carcinoma at inclusion. We analyzed the association between proteoglycan levels and prognosis using Kaplan-Meier and Cox methods. Results: Serum levels of the three proteoglycans and VEGF were increased in patients with advanced hepatocellular carcinoma compared with those without hepatocellular carcinoma or with early hepatocellular carcinoma. In multivariate analysis, high levels of serum endocan (>5 ng/mL) were independently associated with death [HR, 2.84; 95% confidence interval (CI,) 1.18-6.84; P = 0.02], but not with hepatocellular carcinoma occurrence, in patients without hepatocellular carcinoma at baseline. High serum endocan (>5 ng/mL) and syndecan-1 (>50 ng/mL) levels were significantly associated with greater risk of tumor recurrence (P = 0.025) in patients with early hepatocellular carcinoma treated by radiofrequency ablation. In patients with advanced hepatocellular carcinoma, high serumlevels ofendocan (P = 0.004) andsyndecan-1 (P = 0.006) were significantly associated with less favorable overall survival. However, only a high level of serum syndecan-1 (>50 ng/mL) was independently associated with greater risk of death (HR, 6.21 95% CI, 1.90-20.30; P = 0.0025). Conclusion: Serum endocan and syndecan-1 are easily assessable prognostic serum biomarkers of overall survival in alcoholic cirrhosis with and without hepatocellular carcinoma. Impact: These new biomarkers will be useful to manage patients with hepatocellular carcinoma developed on alcoholic cirrhosis. (C) 2013 AACR.
引用
收藏
页码:1343 / 1352
页数:10
相关论文
共 50 条
  • [1] IDENTIFICATION OF SERUM PROTEOGLYCANS AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND ALCOHOLIC CIRRHOSIS
    Nault, J. C.
    Guyot, E.
    Laguillier, C.
    Chevret, S.
    Ganne-Carrie, N.
    N'Kontchou, G.
    Beaugrand, M.
    Seror, O.
    Trinchet, J. -C.
    Lasalle, P.
    Charnaux, N.
    Delhedde, M.
    Sutton, A.
    Nahon, P.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S400 - S401
  • [2] Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis
    Abegunde, Ayokunle T.
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 157 (09) : 677 - 677
  • [3] Hepatocellular carcinoma surveillance in patients with alcoholic cirrhosis
    Jepsen, Peter
    Ott, Peter
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 651 - 653
  • [4] Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis
    Ferrin, Gustavo
    Rodriguez-Peralvarez, Manuel
    Aguilar-Melero, Patricia
    Ranchal, Isidora
    Llamoza, Camilo
    Linares, Clara I.
    Gonzalez-Rubio, Sandra
    Muntane, Jordi
    Briceno, Javier
    Lopez-Cillero, Pedro
    Luis Montero-Alvarez, Jose
    de la Mata, Manuel
    [J]. PLOS ONE, 2015, 10 (03):
  • [5] Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis
    Ressom, Habtom W.
    Xiao, Jun Feng
    Tuli, Leepika
    Varghese, Rency S.
    Zhou, Bin
    Tsai, Tsung-Heng
    Ranjbar, Mohammad R. Nezami
    Zhao, Yi
    Wang, Jinlian
    Di Poto, Cristina
    Cheema, Amrita K.
    Tadesse, Mahlet G.
    Goldman, Radoslav
    Shetty, Kirti
    [J]. ANALYTICA CHIMICA ACTA, 2012, 743 : 90 - 100
  • [6] Alcoholic Cirrhosis and Hepatocellular Carcinoma
    Stickel, Felix
    [J]. BIOLOGICAL BASIS OF ALCOHOL-INDUCED CANCER, 2015, 815 : 113 - 130
  • [7] Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
    Kim, Ji Hyun
    Kang, Seong Hee
    Lee, Minjong
    Youn, Gi Soo
    Kim, Tae Suk
    Jun, Baek Gyu
    Kim, Moon Young
    Kim, Young Don
    Cheon, Gab Jin
    Kim, Dong Joon
    Baik, Soon Koo
    Choi, Dae Hee
    Suk, Ki Tae
    [J]. CANCERS, 2020, 12 (11) : 1 - 16
  • [8] Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
    Oh, Sooyeon
    Lee, Jooho
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (04) : 476 - 479
  • [9] Need for surveillance of hepatocellular carcinoma in patients with alcoholic cirrhosis
    D'Amico, Gennaro
    Bataller, Ramon
    [J]. JOURNAL OF HEPATOLOGY, 2018, 69 (06) : 1219 - 1220
  • [10] Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis RESPONSE
    Jepsen, Peter
    Ott, Peter
    Vilstrup, Hendrik
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 157 (09) : 678 - 678